Review
Open access
Jul 2026
A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect
This review comprehensively summarises the development progress of new drugs approved in 2025, including molecular design, structural modification, structure-activity relationship, and enhancement of drug-like properties to offer valuable insights to pharmaceutical chemists and bring inspiration for future research.
Yi-Ru Bai, Rui-Fang Li, Xin-Hui Zhang et al.
· Journal of Enzyme Inhibition... · 2 citations